Skip to main content

Table 2 Univariate analyses for overall survival in metastatic gastric cancer patients (n = 123)

From: Identification of prognostic factors and surgical indications for metastatic gastric cancer

Variable

Median survival (months)

p value

Age (years)

 

0.362

  >65

13.4

 

  < 65

13.1

 

Sex

 

0.583

  Female

11.1

 

  Male

14.2

 

PS

 

< 0.001

  0, 1, 2

14.2

 

  3

2.4

 

Body mass index (kg/m2)

 

0.242

  < 21

11.1

 

  >21

14.9

 

Hb (g/dL)

 

0.428

  < 12

13.4

 

  >12

13.1

 

NLR

 

< 0.001

  < 3.1

16.5

 

  >3.1

8.2

 

CRP (mg/dL)

 

0.005

  < 0.2

15.4

 

  >0.2

9.8

 

Alb (g/dL)

 

< 0.001

  < 3.5

6.7

 

  >3.5

15.6

 

CEA (ng/mL)

 

0.052

  < 6

14.2

 

  >6

9.7

 

CA19-9 (U/mL)

 

0.003

  < 37

15.3

 

  >37

9.7

 

Tumor location in stomach

 

0.267

  Upper

13.4

 

  Middle

12.3

 

  Lower

14.2

 

  Whole

7.4

 

Histological differentiation

 

0.829

  Differentiated

14.6

 

  Undifferentiated

11.4

 

Adjacent organ invasion

 

0.009

  Yes

7.8

 

  No

14.6

 

Bulky lymph nodes

 

0.011

  Yes

9.3

 

  No

12.5

 

Metastasis to organs

 

0.044

  1 organ

15.4

 

  ≥2 organs

10.1

 

Peritoneal metastasis

 

0.174

  Present

11.1

 

  Absent

16.2

 

Hepatic metastasis

 

0.556

  Present

15.3

 

  Absent

11.4

 

Distant lymph node metastasis

 

0.117

  Present

10.1

 

  Absent

14.6

 

Gastrectomy

 

< 0.0001

  Present

15.6

 

  Absent

7.2

 

Chemotherapy

 

0.007

  Yes

14.4

 

  No

4.7